title: Antibiotic therapy for foot infections in diabetics.
authors.forename: X H
authors.initials: XH
authors.lastname: Hu
authors.forename: L E
authors.initials: LE
authors.lastname: Markson
authors.forename: T A
authors.initials: TA
authors.lastname: Abbott
authors.forename: E J
authors.initials: EJ
authors.lastname: Dasbach
authors.forename: M L
authors.initials: ML
authors.lastname: Berger
mesh_terms: D000667:Ampicillin / Q000191:economics / Q000627:therapeutic use; D015377:Cilastatin / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017719:Diabetic Foot / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000191:economics / Q000627:therapeutic use*; D005534:Foot Diseases / Q000188:drug therapy*; D006801:Humans; D015378:Imipenem / Q000191:economics / Q000627:therapeutic use; D013407:Sulbactam / Q000191:economics / Q000627:therapeutic use
chemical_list: D015377:Cilastatin; D015378:Imipenem; D000667:Ampicillin; D013407:Sulbactam